PLEASANTON, Calif., Jan. 3, 2025 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based test ...
The increase in incidence of early-onset colorectal cancer (CRC) is no longer confined to high-income nations. A recent study found that rates are also rising in Latin America, Asia, and Eastern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback